Article
Genetic variation at IL7 provides mechanistic insights into toxicity to immune checkpoint blockade
2022-04-12
Abstract excerpt
<title>Abstract</title> <p>Although treatment with immune checkpoint blockade (ICB) has transformed outcomes for patients with melanoma (1, 2), it frequently triggers immune related adverse events (irAEs), causing serious morbidity and presenting a major hurdle to immuno-oncology (3, 4). The degree to which germline genetic variation predisposes to irAEs is unknown. Here, studying a cohort of 214 patients receivi...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 0a6f27db-1db1-52d5-9182-53aebc8ccf47
- DOI
- 10.21203/rs.3.rs-1531341/v1
